title: Molecular defects in sarcolemmal glycerophospholipid subclasses in diabetic cardiomyopathy.
abstract: Although still scarcely studied, the phospholipid component of the cell membrane is of absolute importance for cell function. Experimental evidence indicates that individual molecular species of a given phospholipid can influence specific membrane functions. We have examined the changes in molecular species of diacyl and alkenylacyl choline/ethanolamine glycerophospholipid subclasses and those of phosphatidylserine in purified cardiac sarcolemma of healthy and streptozotocin-induced insulin dependent diabetic rats without or with insulin treatment. The relative content of plasmalogens increased in all the phospholipid classes of diabetic sarcolemma under study. Phosphatidylcholine and phosphatidylethanolamine were mostly enriched with molecular species containing linoleic acid in sn-2 position and deprived of the molecular species containing arachidonic acid. The molecular species of phosphatidylserine containing either arachidonic or docosahexaenoic acid were less abundant in membranes from diabetic rats than in membranes from controls. Insulin treatment of diabetic rats restored the species profile of phosphatidylethanolamine and overcorrected the changes in molecular species of phosphatidylcholine. The results suggest that the high sarcolemmal level of plasmalogens and the abnormal molecular species of glycerophospholipids may be critical for the membrane dysfunction and defective contractility of the diabetic heart.
authors.affiliation: Institute of Biochemistry and Medical Chemistry, University of Perugia, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Vecchini
authors.forename: F
authors.initials: F
authors.lastname: Del Rosso
authors.forename: L
authors.initials: L
authors.lastname: Binaglia
authors.forename: N S
authors.initials: NS
authors.lastname: Dhalla
authors.forename: V
authors.initials: V
authors.lastname: Panagia
mesh_terms: D000818:Animals; D009202:Cardiomyopathies / Q000150:complications / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000378:metabolism*; D020404:Glycerophospholipids / Q000145:classification / Q000378:metabolism*; D007328:Insulin / Q000008:administration & dosage; D050356:Lipid Metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012508:Sarcolemma / Q000378:metabolism*
chemical_list: D020404:Glycerophospholipids; D007328:Insulin